Dupilumab was more effective than other biologics in achieving clinical remission in adults and adolescents with several types of severe asthma, based on data presented at the European Respiratory ...

You do your best to manage severe asthma, often taking multiple therapies to keep asthma attacks at bay. 1 Still, life may feel "up in the air" — like your treatments leave your symptoms feeling ...

The World Health Organization (WHO) is preparing updated asthma care guidance, with patient safety expected to play a central ...

PARIS — Pregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright cessation of maintenance treatment, is common, ...

Add Yahoo as a preferred source to see more of our stories on Google. what-is-asthma-jpg The wheezing. The coughing. The extreme and sudden shortness of breath. These are symptoms that are attached to ...

For millions of people around the world, asthma is more than just a breathing problem—it is a chronic and often debilitating condition caused by the immune system's exaggerated response to harmless ...

A large real-world study found semaglutide was associated with nearly 40% fewer asthma attacks and 20% fewer COPD flare-ups.

For many years, the standard treatment for asthma was an inhaler with a medication called albuterol. Only if that wasn’t enough would additional medicines be added. If symptoms became especially bad, ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published in The ...

Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study.

More than half of integrated care systems (ICSs) in England don’t have enough capacity to accurately diagnose childhood ...

Inflammation associated with asthma and other allergic airway diseases can be significantly worsened by exposure to both ...